We report a case of 71-year-old female patient, previously treated with chemotherapy and surgical resection of sigmoid tract of the large bowel for adenocarcinoma (pT3N1M0), who underwent a 18 F-FDG PET/CT for a suspicious hepatic lesion detected at CT scan during follow-up.
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Background
Incidental and unexpected focal 18 F-fluoro-2-deoxyglucose ( 18 F-FDG) uptakes in many organs are relatively frequent and can involve many organs as thyroid [1, 2] , prostate [2] , parotid gland [3] and colon [4] . Breast incidentaloma is commonly considered a breast lesion incidentally and newly detected by imaging techniques performed for an unrelated purpose and especially not for investigating breast diseases. Moreover, unexpected focal 18 F-FDG uptakes can involve breast frequently revealing an unexpected breast cancer [5] [6] [7] [8] ; this means that, despite screening procedures, some lesions are still missed during traditional screening and could be incidentally revealed by 18 F-FDG positron emission tomography (PET).
Case report
A 71-year-old female patient previously treated with chemotherapy and surgical resection of sigmoid tract of the large bowel for adenocarcinoma (pT3, N1, M0) underwent a CT scan during follow-up which was doubtful for a secondary lesion in the VII segment of the liver.
18 F-FDG PET/CT was performed after intravenous administration of 3.5 MBq/kg; total body images were acquired 60 minutes after injection on Discovery ST tomograph (GE -Milwaukee, Wi, USA; 4-slice-CT, 80mA, 120Kv; 3 minutes PET-bed; 128 × 128 matrix, 60 cm field of view) and further abdominal images were also acquired after 120 minutes from injection. The study showed no pathological uptake in the liver both after 60 and 120 minutes but revealed unexpected pathological uptakes in two breast nodules: one localized in the upper-inner-quadrant (UIQ) of the right breast and the other in the upper-external-quadrant of the left breast (UEQ).
( Figure 1 ). The subsequent bilateral mammography confirmed the lesions described with PET/CT, particularly one lesion in the UIQ of the right breast next to the areola with a diameter of 30 mm, the other about 15 mm in the UEQ of the left breast. To study in deep the nature of these lesions the patient underwent breast MRI, which confirmed the suspicious features of both nodules ( Figure 2) . Afterwards she performed a trucut biopsy of the lesions which showed a bilateral localization of papillary carcinoma (both lesion were classified as pT1c) (Figure 3 ). Subsequently the patient underwent to bilateral mastectomy and the biopsy confirmed the presence of breast cancer, while bilateral sentinel nodes biopsy showed no lymph-nodes metastases.
Discussion
In patients affected by cancer workups usually focus on the patient's primary disease, and incidental coexistence of another primary malignant lesion can be missed. The singularity of this case is the bilateral breast incidentaloma histologically confirmed 
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Case report as cancer; to best of our knowledge this is the first reported case in literature discovered with 18 F-FDG PET/CT. 18 F-FDG PET/CT is not currently recommended for primary breast cancer detection because of high false negative rates in the presence of small early breast cancer. Low sensitivity was described for the identification of small non-palpable (< 1 cm) and low-grade malignancies [9] but it showed an added value in the detection of loco regional recurrence or distant metastases in locally advanced breast cancer [10] . Since screening procedure for breast cancer started a reduction of mortality was observed and an extension of lives despite the overdiagnosis still represents a problem. Despite screening procedure for breast cancer the data available in literature report a small number of incidental breast uptakes in patients studied with 18 F-FDG PET/CT for non-breast-related oncological reasons, which suggest that some lesions are still missed during traditional screening procedures [5] [6] [7] [8] . In differentiating benign from malignant lesion SUV max values showed a low accuracy and a cut-off value couldn't be considered [6, 7] . A recently published revision of the literature suggest that prevalence of hypermetabolic lesions in the breast is between 0.36 and 1.84% and overall risk of malignancy is between 18 and 100% [6] . This case report suggests that every breast uptake need further imaging in order to rule out malignancy. Despite being not frequent, breast incidentalomas are clinically relevant showing a high percentage of malignancy and, therefore, need further investigation. 
